Atomoxetine for Treating Attention Deficit Hyperactivity Disorder in Young Children - Contacts and Locations

Atomoxetine for Treating Attention Deficit Hyperactivity Disorder in Young Children

This study is ongoing, but not recruiting participants.

Study NCT00254462. Last updated on August 28, 2008. Information provided by National Institute of Mental Health (NIMH)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00254462

Locations


United States, Nebraska
	University of Nebraska Medical Center
	Omaha, Nebraska, United States, 68198

United States, New York
	New York State Psychiatric Institute
	New York, New York, United States, 10032

United States, North Carolina
	Duke University Medical Center
	Durham, North Carolina, United States, 27705

Sponsors and Collaborators

National Institute of Mental Health (NIMH)

Investigators


Principal Investigator:	Christopher J. Kratochvil, MD	University of Nebraska